Abstract:Background: Highly active anti-retroviral therapy (HAART) is the current HIV/AIDS treatment modality. Despite the fact that HAART is very effective in suppressing HIV-1 replication and reducing the mortality of HIV/AIDS patients, it has become increasingly clear that HAART does not offer an ultimate cure to HIV/AIDS. The high cost of the HAART regimen has impeded its delivery to over 90% of the HIV/AIDS population in the world. This reality has urgently called for the need to develop inexpensive alternative anti-HIV/AIDS therapy. This need has further manifested by recent clinical trial failures in anti-HIV-1 vaccines and microbicides. In the current study, we characterized a panel of extracts of traditional Chinese medicinal herbal plants for their activities against HIV-1 replication.Methods: Crude and fractionated extracts were prepared from various parts of nine traditional Chinese medicinal herbal plants in Hainan Island, China. These extracts were first screened for their anti-HIV activity and cytotoxicity in human CD4+ Jurkat cells. Then, a single-round pseudotyped HIV-luciferase reporter virus system (HIV-Luc) was used to identify potential anti-HIV mechanisms of these extracts.Results: Two extracts, one from Euphorbiaceae, Trigonostema xyphophylloides (TXE) and one from Dipterocarpaceae, Vatica astrotricha (VAD) inhibited HIV-1 replication and syncytia formation in CD4+ Jurkat cells, and had little adverse effects on host cell proliferation and survival. TXE and VAD did not show any direct inhibitory effects on the HIV-1 RT enzymatic activity. Treatment of these two extracts during the infection significantly blocked infection of the reporter virus. However, pre-treatment of the reporter virus with the extracts and treatment of the extracts post-infection had little effects on the infectivity or gene expression of the reporter virus.Conclusion: These results demonstrate that TXE and VAD inhibit HIV-1 replication likely by blocking HIV-1 interaction with target cells, i.e., the interaction between gp120 and CD4/CCR5 or gp120 and CD4/CXCR4 and point to the potential of developing these two extracts to be HIV-1 entry inhibitors.

Structure and Anti-HIV Activity of Betulinic Acid Analogues

Advances in Research on Betulinic Acid Derivatives as Anti-HIV Agents

Understanding the Structure-Activity Relationship of Betulinic Acid Derivatives As Anti-Hiv-1 Agents by Using 3D-QSAR and Docking

Recent Advances of Betulinic Acid and Its Derivatives

[Advances in the Study of Structural Modifications and Biological Activities of Betulinic Acids].

Fluorinated Betulinic Acid Derivatives and Evaluation of Their Anti-Hiv Activity

3D-QSAR studies on betulinic acid and betulin derivatives as anti-HIV-1 agents using CoMFA and CoMSIA

Discovery and Synthesis of Novel Beesioside I Derivatives with Potent Anti-Hiv Activity.

Conjugates of Betulin Derivatives with AZT As Potent Anti-Hiv Agents

Research Progress and Foreground of Betulin and Betulinic Acid

Recent advances in natural anti‐HIV triterpenoids and analogs

Coumarin-based derivatives with potential anti-HIV activity

[Anti-HIV-1 activity and structure-activity relationship of pyranocoumarin analogs].

The discovery of a class of novel HIV-1 maturation inhibitors and their potential in the therapy of HIV

Synthesis and Preliminary Anti-Hiv Activities of Andrographolide Derivatives

Inhibition of HIV-1 Entry by Extracts Derived from Traditional Chinese Medicinal Herbal Plants

Studying on Extraction of Betulin from the White Birch and Synthesis of Betulinic Acid

Synthesis and Biological Evaluation of a Series of 2-(((5-akly/aryl-1h-pyrazol-3-yl)methyl)thio)-5-alkyl-6-(cyclohexylmethyl)-pyrimidin-4(3h)-ones As Potential HIV-1 Inhibitors.

Research progress in the anticancer activity and structure modifications of betulin and betulinic acid

New developments in natural products-based anti-AIDS research

Design, Synthesis, and Mechanism Study of Dimerized Phenylalanine Derivatives As Novel HIV-1 Capsid Inhibitors.